OCDX - Ortho Clinical Diagnostics EPS beats by $0.07 beats on revenue
Ortho Clinical Diagnostics (NASDAQ:OCDX): Q3 Non-GAAP EPS of $0.21 beats by $0.07; GAAP EPS of $0.06 beats by $0.07. Revenue of $522.5M (+15.8% Y/Y) beats by $40.79M. Press Release
For further details see:
Ortho Clinical Diagnostics EPS beats by $0.07, beats on revenue